Reference range(s)
The reference ranges listed below are valid on this date of January 22, 2025.
Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
---|---|---|---|---|---|---|---|---|---|
Encephalopathy, Interpretation, S | ALL | See report. | |||||||
AMPA-R Ab CBA, S | ALL | See report. | |||||||
Amphiphysin Ab, S | ALL | See report. | |||||||
AGNA-1, S | ALL | See report. | |||||||
ANNA-1, S | ALL | See report. | |||||||
ANNA-2, S | ALL | See report. | |||||||
ANNA-3, S | ALL | See report. | |||||||
CASPR2-IgG CBA, S | ALL | See report. | |||||||
GABA-B-R Ab CBA, S | ALL | See report. | |||||||
GAD65 Ab Assay, S | ALL | See report. | |||||||
GFAP IFA, S | ALL | See report. | |||||||
LGI1-IgG CBA, S | ALL | See report. | |||||||
mGluR1 Ab IFA, S | ALL | See report. | |||||||
NIF IFA, S | ALL | See report. | |||||||
NMDA-R Ab CBA, S | ALL | See report. | |||||||
PCA-1, S | ALL | See report. | |||||||
PCA-2, S | ALL | See report. | |||||||
PCA-Tr, S | ALL | See report. | |||||||
CRMP-5-IgG, S | ALL | See report. | |||||||
IFA Notes | ALL | See report. | |||||||
Neurochondrin IFA, S | ALL | See report. | |||||||
Septin-7 IFA, S | ALL | See report. | |||||||
DPPX Ab CBA, S | ALL | See report. | |||||||
IgLON5 CBA, S | ALL | See report. | |||||||
PDE10A Ab IFA, S | ALL | See report. | |||||||
TRIM46 Ab IFA, S | ALL | See report. |